Development of the first generation c-met kinase inhibitors: beginning of a path to a new treatment for cancer

Mol Cancer Ther. 2011 Nov;10(11):2022-3. doi: 10.1158/1535-7163.MCT-11-0714.
No abstract available

Publication types

  • Comment

MeSH terms

  • Hepatocyte Growth Factor / antagonists & inhibitors*
  • Hepatocyte Growth Factor / pharmacology*
  • Humans
  • Neoplasm Invasiveness*
  • Neoplasms / pathology*
  • Proto-Oncogene Proteins c-met / antagonists & inhibitors*
  • Proto-Oncogene Proteins c-met / metabolism*

Substances

  • Hepatocyte Growth Factor
  • Proto-Oncogene Proteins c-met